Journal of Clinical Research in Paramedical Sciences
The Official Journal of Paramedical School, KUMS
Image Credit:J Clin Res Paramed Sci
Outline
Multidrug resistance in Pseudomonas aeruginosa and Enterobacter cloacae isolated from intensive care units of Qazvin and Tehran hospitals
Authors
Abstract
Introduction: Pseudomonas aeruginosa and Enterobacter cloacae are the most common organisms involved in clinical disease among patients admitted in ICUs. The treatment of these infections is often difficult due to several virulence factors and drug resistance
mechanisms. The aim of this study was to evaluate multidrugresistance pattern among clinical P. aeruginosa and E. cloacae isolates collected from ICUs.
Methods: In total, 82 and 49 P. aeruginosa and E. cloacae isolates were collected from ICUs of Tehran and Qazvin hospitals. The species identification was performed by standard laboratory methods. Antimicrobial susceptibility and multidrug resistance (MDR) pattern
were further evaluated by Kirby-Baure method according to CLSI guideline.
Results: In this study, the highest resistance rate was shown to cefpodoxime (98.8%) and cefotaxime (97.6%) in P. aeruginosa and to amoxicillin-clavulanic (98%) acid and ampicillin (95.9%) in E. cloacae isolates. Twenty six (53.1%) E. cloacae and 43 (52.4%) P. aeruginosa isolates showed the multidrug resistance pattern.
Conclusion: The present study showed the considerable frequency of MDR pattern among P. aeruginosa and E. cloacae isolates collected from studied hospitals. Therefore, there is need for efficient infection control and appropriate therapeutic practices, especially in ICUs.
Highlights
References
- 1.The References of this article is available on PDF.
Copyright
© 2014, Journal of Clinical Research in Paramedical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Detection of ESBLs and MDR in Pseudomonas aeruginosa in a Tertiary-Care Teaching Hospital
Tavajjohi Z, Moniri R. Detection of ESBLs and MDR in Pseudomonas aeruginosa in a Tertiary-Care Teaching Hospital. Arch Clin Infect Dis. 2011;6(1):. doi:
Prevalence of blaOxa10 Type Beta-lactamase Gene in Carbapenemase Producing Pseudomonas aeruginosa Strains Isolated From Patients in Isfahan
Golshani Z, Sharifzadeh A. Prevalence of blaOxa10 Type Beta-lactamase Gene in Carbapenemase Producing Pseudomonas aeruginosa Strains Isolated From Patients in Isfahan. Jundishapur J Microbiol. 2013;6(5):e9002. doi: https://doi.org/10.5812/jjm.9002
Emergence of Colistin Resistance Among Carbapenem-Resistant MDR Pseudomonas aeruginosa Isolates from Northeast Iran: Determination of MIC Values
Ghavidel M, Zeraatkar S, Tahan M, Rostami O, Neshani A. Emergence of Colistin Resistance Among Carbapenem-Resistant MDR Pseudomonas aeruginosa Isolates from Northeast Iran: Determination of MIC Values. Arch Clin Infect Dis. 2025;20(6):e162460. doi: https://doi.org/10.5812/archcid-162460
Occurrence of a Multidrug Resistant Pseudomonas aeruginosa Strains in Hospitalized Patients in Southwest of Iran: Characterization of Resistance Trends and Virulence Determinants
Izadi Pour Jahromi S, Mardaneh J, Sharifi A, Pezeshkpour V, Behzad-Behbahani A, et al. Occurrence of a Multidrug Resistant Pseudomonas aeruginosa Strains in Hospitalized Patients in Southwest of Iran: Characterization of Resistance Trends and Virulence Determinants. Jundishapur J Microbiol. 2018;11(4):e57341. doi: https://doi.org/10.5812/jjm.57341
Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran
Ghotaslou R, Sadeghi MR, Akhi MT, Hasani A, Asgharzadeh M. Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing Enterobactericeae Isolated from Hospitalized Patients in Azerbaijan, Iran. Iran J Pharm Res. 2018;17(Suppl):e124751. doi: https://doi.org/10.22037/ijpr.2018.2206
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 2
Last Update: 1 week ago
- CrossRef: 0
Last Update: 2 hours ago
- OpenAlex: 0
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 5 days ago